Applied BioCode Corporation announced the resignation of Michael Sean Aye as research and development officer, effective September 23, 2023. Reason for the change: Personal career planning.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.8 TWD | -0.50% | -1.00% | -21.74% |
04-15 | Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only | CI |
03-21 | Applied BioCode Announces CEO Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.74% | 50.18M | |
-27.58% | 10.26B | |
+31.87% | 3.04B | |
-7.17% | 2.94B | |
-13.62% | 2.19B | |
-15.92% | 1.72B | |
+65.80% | 1.4B | |
+28.92% | 780M | |
-2.18% | 736M | |
-16.12% | 560M |
- Stock Market
- Equities
- 6598 Stock
- News Applied BioCode Corporation
- Applied BioCode Corporation Announces the Resignation of Michael Sean Aye as Research and Development Officer